Clinical Trials Directory

Trials / Unknown

UnknownNCT04207632

Quantifying Muscle Tone in Patients With Brain Injury - a Feasibility Study

Status
Unknown
Phase
Study type
Observational
Enrollment
5 (estimated)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
5 Years – 99 Years
Healthy volunteers

Summary

This project will determine the feasibility and validity of measuring elbow muscle flexor stiffness in a population of patients with sub-acute severe acquired brain injury using two measurement methods, the portable spasticity assessment device (PSAD) (Movotec, Charlottenlund, Denmark) and an ultrasound measurement called shear wave sonoelastography (SWE).

Detailed description

The purpose of this study is to investigate the feasibility and validity of measuring hypertonia in the elbow flexors of patients with severe acquired brain injury in their sub-acute rehabilitation and collect data to determine the necessary size for a definitive study to determine the clinimetrics of the test methods. The long-term goal is to establish a valid and clinically feasible method for physiotherapists to quantify muscle tone in patients with neurological disorders. The study hypotheses are: 1. SWE, PSAD and Modified Ashworth Scale (MAS) measurements can be obtained for elbow flexion hypertonia in all patients (no missing data due to test procedure), 2. SWE and PSAD have a moderate to good intra-day intra-tester reliability (ICC two-way mixed effects model with absolute agreement. ICC\>0.5, Bland Altman) 3. Passive muscle stiffness measured using the PSAD and SWE have a fair concurrent validity with MAS (Spearmans correlation \>0.3) 4. SWE and PSAD are responsive in measuring a reduction of the effect of routine clinical treatment of the hypertonic muscles with botulinum toxin type A (BTX-A) (paired T-test or Wilcoxon test, p\>0.05)

Conditions

Interventions

TypeNameDescription
DRUGBotulinum toxin type A injectionUltrasound-guided BoNT-A injection in biceps brachii or brachialis

Timeline

Start date
2020-04-01
Primary completion
2021-01-15
Completion
2021-04-01
First posted
2019-12-23
Last updated
2020-02-26

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04207632. Inclusion in this directory is not an endorsement.